Instil Bio, Inc. (TIL) Stock
Healthcare · Biotechnology · Member of Other US Stocks
Instil Bio, Inc. (TIL) closed at USD 6.13 on 2026-10-15, a change of -65.4 % over the past year, with a market capitalization of USD 40.08M.
Instil Bio, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-15 | 6.13 |
| 2026-10-14 | 5.95 |
| 2026-10-13 | 6.18 |
| 2026-10-12 | 6.58 |
| 2026-10-09 | 6.74 |
| 2026-10-08 | 6.56 |
| 2026-10-07 | 6.90 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Instil Bio, Inc. key figures
- Previous close
- USD 6.13 (2026-10-15)
- 1-year change
- -65.4 %
- Market cap
- USD 40.08M
- Enterprise value
- USD 57.82M
- P/E ratio (trailing)
- -1.33
- P/E ratio (forward)
- -0.40
- EPS (trailing)
- -4.43
- EPS (forward)
- -14.64
- PEG ratio
- n/a
- Price to book
- 0.37
- Revenue growth
- n/a
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 10.88
- Employees
- 17
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Instil Bio, Inc. and compare it with other stocks.
Analyze TILAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Instil Bio, Inc. shares.